Breaking News

Wednesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
SGMO

Sangamo

$11.20

-0.4 (-3.45%)

, LXRX

Lexicon

$14.61

-0.28 (-1.88%)

04:55
08/16/17
08/16
04:55
08/16/17
04:55
Conference/Events
Wedbush PacGrow to hold a conference »

Wedbush PacGrow…

SGMO

Sangamo

$11.20

-0.4 (-3.45%)

LXRX

Lexicon

$14.61

-0.28 (-1.88%)

BPMC

Blueprint Medicines

$45.99

0.19 (0.41%)

AKAO

Achaogen

$17.37

1.05 (6.43%)

NTLA

Intellia Therapeutics

$16.55

-0.55 (-3.22%)

NVCR

Novocure

$19.25

0.2 (1.05%)

MGEN

Miragen Therapeutics

$9.61

-0.11 (-1.13%)

TNDM

TNDM

UTHR

United Therapeutics

$129.76

0.08 (0.06%)

SRRA

Sierra Oncology

$1.56

-0.02 (-1.27%)

CLSD

Clearside Biomedical

$6.91

-0.19 (-2.68%)

VRNA

Verona Pharma

$12.20

-0.04 (-0.33%)

BLUE

bluebird bio

$97.05

0.45 (0.47%)

EIGR

Eiger BioPharmaceuticals

$8.08

0.075 (0.94%)

EPZM

Epizyme

$13.30

0.05 (0.38%)

MMSI

Merit Medical

$41.05

0.65 (1.61%)

NVTR

Nuvectra

$11.73

-0.23 (-1.92%)

CTMX

CytomX Therapeutics

$14.00

-0.64 (-4.37%)

OBSV

ObsEva

$7.69

-0.09 (-1.16%)

ABUS

Arbutus Biopharma

$3.75

0.1 (2.74%)

ISRG

Intuitive Surgical

$985.37

20.81 (2.16%)

XNCR

Xencor

$21.44

-0.19 (-0.88%)

GBT

Global Blood Therapeutics

$28.50

-0.8 (-2.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

  • 21

    Aug

  • 07

    Sep

  • 27

    Sep

  • 28

    Sep

Tuesday
SGMO

Sangamo

$11.60

1.35 (13.17%)

, LXRX

Lexicon

$14.89

0.27 (1.85%)

08:47
08/15/17
08/15
08:47
08/15/17
08:47
Conference/Events
Wedbush PacGrow to hold a conference »

Wedbush PacGrow…

SGMO

Sangamo

$11.60

1.35 (13.17%)

LXRX

Lexicon

$14.89

0.27 (1.85%)

BPMC

Blueprint Medicines

$45.80

-0.31 (-0.67%)

AKAO

Achaogen

$16.32

-0.33 (-1.98%)

NTLA

Intellia Therapeutics

$17.10

0.17 (1.00%)

NVCR

Novocure

$19.05

0.75 (4.10%)

MGEN

Miragen Therapeutics

$9.72

-1.84 (-15.92%)

TNDM

TNDM

UTHR

United Therapeutics

$129.68

1.45 (1.13%)

SRRA

Sierra Oncology

$1.58

0.05 (3.27%)

CLSD

Clearside Biomedical

$7.10

0.06 (0.85%)

VRNA

Verona Pharma

BLUE

bluebird bio

$96.60

2.65 (2.82%)

EIGR

Eiger BioPharmaceuticals

$8.00

-0.05 (-0.62%)

EPZM

Epizyme

$13.25

0.15 (1.15%)

MMSI

Merit Medical

$40.40

0.65 (1.64%)

NVTR

Nuvectra

$11.96

0.31 (2.66%)

CTMX

CytomX Therapeutics

$14.64

0.66 (4.72%)

OBSV

ObsEva

$7.78

0.145 (1.90%)

ABUS

Arbutus Biopharma

$3.65

0.05 (1.39%)

ISRG

Intuitive Surgical

$964.56

22.31 (2.37%)

XNCR

Xencor

$21.63

0.25 (1.17%)

GBT

Global Blood Therapeutics

$29.30

0.75 (2.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

  • 15

    Aug

  • 15

    Aug

  • 21

    Aug

  • 07

    Sep

  • 27

    Sep

  • 28

    Sep

Over a week ago
CTMX

CytomX Therapeutics

$14.78

1.13 (8.28%)

04:55
08/09/17
08/09
04:55
08/09/17
04:55
Conference/Events
CytomX Therapeutics management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Aug

  • 15

    Aug

CTMX

CytomX Therapeutics

$13.65

0.03 (0.22%)

16:24
08/07/17
08/07
16:24
08/07/17
16:24
Earnings
CytomX Therapeutics reports Q2 EPS (69c), consensus (37c) »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

  • 09

    Aug

  • 15

    Aug

CTMX

CytomX Therapeutics

$13.23

-0.13 (-0.97%)

12:06
08/03/17
08/03
12:06
08/03/17
12:06
Conference/Events
CytomX Therapeutics management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

  • 09

    Aug

  • 15

    Aug

Over a month ago
CTMX

CytomX Therapeutics

$15.41

0.96 (6.64%)

, ABBV

AbbVie

$72.92

0.53 (0.73%)

08:10
06/29/17
06/29
08:10
06/29/17
08:10
Hot Stocks
CytomX receives $15M development milestone payment from AbbVie »

CytomX Therapeutics…

CTMX

CytomX Therapeutics

$15.41

0.96 (6.64%)

ABBV

AbbVie

$72.92

0.53 (0.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTMX

CytomX Therapeutics

$14.45

-0.45 (-3.02%)

08:15
06/28/17
06/28
08:15
06/28/17
08:15
Hot Stocks
CytomX Therapeutics treats first patient in Phase 1/2 PROCLAIM-CX-2009 trial »

CytomX Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a quarter ago
CTMX

CytomX Therapeutics

$15.09

0.47 (3.21%)

16:09
05/15/17
05/15
16:09
05/15/17
16:09
Hot Stocks
CytomX CFO Bob Goeltz leaving, to be replaced by Debanjan Ray »

CytomX Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

BL

BlackLine

$31.92

0.05 (0.16%)

, CTMX

CytomX Therapeutics

$14.62

0.09 (0.62%)

08:30
05/15/17
05/15
08:30
05/15/17
08:30
Options
Three new option listings and five option delistings on May 15th »

New option listings for…

BL

BlackLine

$31.92

0.05 (0.16%)

CTMX

CytomX Therapeutics

$14.62

0.09 (0.62%)

BCEI

Bonanza Creek

$38.25

-0.74 (-1.90%)

EXAR

Exar

FNBC

First NBC Bank

LFL

LATAM Airlines

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

CTMX

CytomX Therapeutics

$14.64

-0.24 (-1.61%)

08:18
05/05/17
05/05
08:18
05/05/17
08:18
Earnings
CytomX Therapeutics reports Q1 EPS (23c), consensus (52c) »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.